EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY 4.0

Cross-Regional Comparison of CDCA8 Gene Expression and Prognosis in Glioma Patients: A Meta-Analysis Based on CGGA and TCGA Databases

Wei Gong, Zuodong Yuan, Baiwei Zhang, Chansachak Chea, Chunlei Tian, Fei Ye

Clinical and Translational Neuroscience · 05.06.2026 · 10 (2) · 14

DOI: 10.3390/ctn10020014 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Clinical and Translational Neuroscience, online erschienen am 05.06.2026. Verfasst von Wei Gong und 5 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

CDCA8 is frequently overexpressed in malignant tumors and linked to poor prognosis. This study evaluated the prognostic significance of CDCA8 expression in glioma patients using the CGGA and TCGA datasets.

Methods

Clinical and expression data of glioma patients from CGGA and TCGA were analyzed. CDCA8 expression was compared across subgroups based on tumor grade (GBM vs. LGG) and IDH mutation status, and meta-analyses were performed to assess inter-database differences.

Results

This study included 1125 glioma patients from CGGA and TCGA. CDCA8 expression was higher in TCGA GBM (p < 0.001) but comparable between databases in LGG (p = 0.501). CGGA showed lower CDCA8 in IDH-mutant gliomas (p < 0.001), with no difference in IDH-wildtype cases (p = 0.154). CGGA patients had longer overall survival in all above subgroups. Meta-analysis found no significant prognostic association of CDCA8 in GBM, IDH-wildtype and IDH-mutant gliomas. In LGG, high CDCA8 was significantly linked to reduced adverse events (p < 0.001, OR = 0.22, 95% CI [0.11–0.43]).

Conclusion

CDCA8 has grade-dependent prognostic roles in gliomas. Its overexpression correlates with poor prognosis in GBM but favorable outcomes in LGG. Inter-database variations support CDCA8 as a promising prognostic biomarker for LGG, and reflect the influences of regional, therapeutic and genetic factors.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Gong, W., Yuan, Z., Zhang, B., Chea, C., Tian, C., & Ye, F. (2026). Cross-Regional Comparison of CDCA8 Gene Expression and Prognosis in Glioma Patients: A Meta-Analysis Based on CGGA and TCGA Databases. Clinical and Translational Neuroscience, 10(2), 14. https://doi.org/10.3390/ctn10020014

Vancouver

Gong W, Yuan Z, Zhang B, Chea C, Tian C, Ye F. Cross-Regional Comparison of CDCA8 Gene Expression and Prognosis in Glioma Patients: A Meta-Analysis Based on CGGA and TCGA Databases. Clinical and Translational Neuroscience. 2026;10(2):14. doi:10.3390/ctn10020014

BibTeX
@article{Gong2026,
  author = {Gong, Wei and Yuan, Zuodong and Zhang, Baiwei and Chea, Chansachak and Tian, Chunlei and Ye, Fei},
  title = {Cross-Regional Comparison of CDCA8 Gene Expression and Prognosis in Glioma Patients: A Meta-Analysis Based on CGGA and TCGA Databases},
  journal = {Clinical and Translational Neuroscience},
  year = {2026},
  volume = {10},
  number = {2},
  pages = {14},
  doi = {10.3390/ctn10020014}
}
Kostenlos starten →